US: Stocks open little changed
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[NEW YORK] The S&P 500 edged lower on Monday, retreating from record peaks despite news that Endo International would buy Par Pharmaceutical Holdings in the latest pharmaceutical merger.
Five minutes into trade, the broad-based S&P 500 was at 2,121.61, down 1.12 points. The index closed at records on Thursday and Friday.
The Dow Jones Industrial Average added 1.30 at 18,273.86, while the tech-rich Nasdaq Composite Index dipped 7.72 to 5,040.57.
Endo International announced a US$8.05 billion acquisition deal for privately held US firm Par to strengthen its generic drugs business. The deal is expected to generate US$175 million in savings within 12 months after the transaction is completed. Endo shares fell 2.1 per cent.
The calendar has no major economic reports Monday, but the schedule this week includes minutes from the Federal Reserve's April monetary policy meeting and earnings from Wal-Mart Stores.
AFP
Share with us your feedback on BT's products and services
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report